E-LIB Suche - Ergebnisse für: Navarro Mendivil, Alejandro

1

A phase Ib/II study of HER3-targeting lumretuzumab in combi..:

Cejalvo, Juan-Miguel ; Jacob, Wolfgang ; Fleitas Kanonnikoff, Tania...
ESMO Open. 4 (2019) 4 - p. e000532 , 2019

Link: https://doi.org/10.1136/..

2

High levels of chromosomal aberrations negatively associate..:

Iranzo Gómez, Patricia ; Pardo Aranda, Nuria ; Callejo Perez, Ana...
Journal for ImmunoTherapy of Cancer;10(4). , 2022

Link: https://hdl.handle.net/1..

3

Prognostic Value of Clinical Staging According to TNM in Pa..:

Trigo, José Manuel ; Sanchez Gastaldo, Amparo ; Navarro Mendivil, Alejandro...
JTO Clinical and Research Reports;3(1). , 2022

Link: https://hdl.handle.net/1..

4

Phase Ib/II study of ceritinib in combination with ribocicl..:

Santoro, Armando ; Su, Wu-Chou ; Navarro Mendivil, Alejandro...
Lung Cancer;166. , 2022

Link: https://hdl.handle.net/1..

5

Overview of Checkpoint Inhibitors Mechanism of Action: Role..:

Iranzo Gómez, Patricia ; Callejo Perez, Ana ; Assaf Pastrana, Juan David...
Frontiers in Medicine;9. , 2022

Link: https://hdl.handle.net/1..

6

Molecular profiling of long-term responders to immune check..:

Navarro Mendivil, Alejandro ; Callejo Perez, Ana ; Iranzo Gómez, Patricia...
Molecular Oncology;15(4). , 2021

Link: https://hdl.handle.net/1..

7

Efficacy of chemotherapy for malignant pleural mesothelioma..:

Cedres Perez, Susana ; Assaf, Juan David ; Iranzo Gómez, Patricia...
Scientific Reports;11. , 2021

Link: https://hdl.handle.net/1..

8

Interrelations between Patients' Clinicopathological Charac..:

Callejo Perez, Ana ; Iranzo Gómez, Patricia ; Diaz-Mejia, Nely...
Cancers;13(13). , 2021

Link: https://hdl.handle.net/1..

9

A Phase II Trial of Prexasertib (LY2606368) in Patients Wit..:

Byers, Lauren Averett ; Navarro Mendivil, Alejandro ; Schaefer, Eric...
Clinical Lung Cancer;22(6). , 2021

Link: https://hdl.handle.net/1..

10

Nivolumab and Ipilimumab as Maintenance Therapy in Extensiv..:

Owonikoko, Taofeek ; Park, Keunchil ; Govindan, Ramaswamy...
Journal of clinical oncology;39(12). , 2021

Link: https://hdl.handle.net/1..

11

Brain Penetration of Lorlatinib: Cumulative Incidences of C..:

Shaw, Alice Tsang ; Johnson, Melissa L ; Navarro Mendivil, Alejandro...
Targeted Oncology;15. , 2020

Link: https://hdl.handle.net/1..

12

Analysis of Expression of Programmed Cell Death 1 Ligand 1 ..:

Cedrés, Susana ; Ponce-Aix, Santiago ; Zugazagoitia, Jon...
PLOS ONE. 10 (2015) 3 - p. e0121071 , 2015

Link: https://doi.org/10.1371/..

13

A phase Ib/II study of HER3-targeting lumretuzumab in combi..:

Cejalvo, Juan M ; Jacob, Wolfgang ; Fleitas Kanonnikoff, Tania...
Cejalvo JM, Jacob W, Fleitas Kanonnikoff T, Felip E, Navarro Mendivil A, Martinez Garcia M. et al. A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer. ESMO Open. 2019 Jul 22;4(4):e000532. DOI 10.1136/esmoopen-2019-000532. ,

Link: http://hdl.handle.net/10..

14

A phase Ib/II study of HER3-targeting lumretuzumab in combi..:

Enriqueta Felip ; Juan-Miguel Cejalvo ; Wolfgang Jacob...
https://esmoopen.bmj.com/content/4/4/e000532.full. , 2019

Link: https://doi.org/10.1136/..

15

Analysis of expression of programmed cell death 1 ligand 1 ..:

Susana Cedrés ; Santiago Ponce-Aix ; Jon Zugazagoitia...
https://doi.org/10.1371/journal.pone.0121071. , 2015

Link: https://doi.org/10.1371/..